Rapid Dose Therapeutics Corp. announced earnings results for the third quarter ended November 30, 2019. For the third quarter, the company announced negative total revenue was CAD 890,473 compared to total Revenue of CAD 2,206 a year ago. Operating loss was CAD 2.791 million compared to CAD 1.005 million a year ago. Net loss was CAD 3.018 million compared to CAD 1.005 million a year ago. Basic loss per share was CAD 0.04 compared to CAD 0.02 a year ago. For the nine months, total revenue was CAD 40,206 compared to CAD 2,206 a year ago. Operating loss was CAD 6.697 million compared to CAD 1.808 million a year ago. Net loss was CAD 6.993 million compared to CAD 1.808 million a year ago. Basic loss per share was CAD 0.09 compared to CAD 0.03 a year ago.